John Frazer to Zebrafish
This is a "connection" page, showing publications John Frazer has written about Zebrafish.
Connection Strength
4.765
-
Diverse Epithelial Lymphocytes in Zebrafish Revealed Using a Novel Scale Biopsy Method. J Immunol. 2024 Dec 15; 213(12):1902-1914.
Score: 0.871
-
Dynamic Changes in Lymphocyte Populations Establish Zebrafish as a Thymic Involution Model. J Immunol. 2024 Jun 01; 212(11):1733-1743.
Score: 0.839
-
Tackling Acute Lymphoblastic Leukemia-One Fish at a Time. Int J Mol Sci. 2019 Oct 25; 20(21).
Score: 0.610
-
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish. J Vis Exp. 2019 02 22; (144).
Score: 0.582
-
Unusual fluorescent granulomas and myonecrosis in Danio rerio infected by the microsporidian pathogen Pseudoloma neurophilia. Zebrafish. 2014 Jun; 11(3):283-90.
Score: 0.415
-
Shared acquired genomic changes in zebrafish and human T-ALL. Oncogene. 2011 Oct 13; 30(41):4289-96.
Score: 0.339
-
Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia. 2009 Oct; 23(10):1825-35.
Score: 0.297
-
The axillary lymphoid organ is an external, experimentally accessible immune organ in the zebrafish. J Exp Med. 2025 Jun 02; 222(6).
Score: 0.222
-
Targeted sequencing of candidate genes of dyslipidemia in Punjabi Sikhs: Population-specific rare variants in GCKR promote ectopic fat deposition. PLoS One. 2019; 14(8):e0211661.
Score: 0.150
-
Molecularly distinct models of zebrafish Myc-induced B cell leukemia. Leukemia. 2019 02; 33(2):559-562.
Score: 0.144
-
Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia. 2019 02; 33(2):333-347.
Score: 0.140
-
Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 2012 Jun 14; 119(24):5621-31.
Score: 0.090
-
A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models. Leukemia. 2020 12; 34(12):3398-3403.
Score: 0.040
-
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo. Mol Cancer Ther. 2013 Nov; 12(11):2367-77.
Score: 0.025